National Institute for Health and Care Research logo
National Institute for Health and Care Research

Broad Call for Interventions Improving Outcomes in Adults with Faecal Incontinence

Funds UK trials evaluating clinical and cost-effectiveness of faecal-incontinence care.

Value for money is one of the explicit criteria peer reviewers and the funding committee weigh when assessing every application, alongside how ready the proposed intervention is for HTA-style evaluation. Outline applications need a 5-page research plan plus two mandatory one-page uploads: a flow diagram of the study design and participant flow, and a references list; a one-page logic model is opti

The Health Technology Assessment Programme wants studies evaluating the clinical and cost-effectiveness of interventions improving outcomes for adults with faecal incontinence, from outpatient measures (transanal irrigation, biofeedback, pelvic floor therapy, neuromodulation, medication management) to more invasive procedures (implanted neuromodulation, surgical repair of structural abnormalities). It intends to fund more than one study from this broad call.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.No fixed schedule
Next deadlineiThe next date applications are due. Rolling means you can apply any time.6 Jan 2027
Decision timeiTypical time from the deadline to the funder's decision.-
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.-
Funding pooliThe total budget available across all awards in this round.-

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides →
European Commission logo
Scheduled

Clinical trials for advancing innovative interventions for neurodegenerative diseases

🇪🇺European Commission · European Union

Funds early clinical trials of safer, more effective interventions for non-rare neurodegenerative diseases.

MedtechBiotech
€10MApr'27
European Commission logo
Scheduled

Independent Living and Inclusion for Persons with Disabilities

🇪🇺European Commission · European Union

Funds person-centred health, care and technology that help people with disabilities live independently and belong in their communities.

MedtechBiotech
€6M – €8MApr'27
European Commission logo
Scheduled

Innovative healthcare interventions for non-communicable diseases

🇪🇺European Commission · European Union

Funds €7–8M projects that validate innovative interventions for cardiovascular, metabolic, respiratory or kidney disease.

BiotechMedtech
€7M – €8MApr'27
European Commission logo
Scheduled

Equitable Cancer Care Economics and Outcomes

🇪🇺European Commission · European Union

Funds three €5–7M projects that make cancer control more equitable, effective and cost-aware for patients and families.

MedtechBiotech
€5M – €7MSep'27
European Commission logo
Scheduled

International AI Partnerships for Local Innovation

🇪🇺European Commission · European Union

Funds two €1.5M projects that adapt European AI to local data, innovation hubs and real-world challenges in low- and middle-income countries.

AgritechAI+2
€1.5MMar'27
Warwick Innovations (University of Warwick) logo
Open

Warwick Innovations Proof of Concept Fund

🇬🇧Warwick Innovations · United Kingdom

Supports University of Warwick researchers with internal proof-of-concept funding so registered discoveries can move toward commercialization.

BiotechMedtech+3